Donald G Morris
Overview
Explore the profile of Donald G Morris including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
144
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brenner D, OSullivan D, Jarada T, Yusuf A, Boyne D, Mather C, et al.
Lung Cancer
. 2022 Dec;
175:60-67.
PMID: 36463730
Objectives: While Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors have been shown to be effective in phase III randomized trials, the value of targeted therapies has been challenging to...
2.
Chan A, Enwere E, McIntyre J, Wilson H, Nwaroh C, Wiebe N, et al.
J Pathol Clin Res
. 2020 May;
6(4):252-262.
PMID: 32391646
CCNE1 amplification is a recurrent alteration associated with unfavourable outcome in tubo-ovarian high-grade serous carcinoma (HGSC). We aimed to investigate whether immunohistochemistry (IHC) can be used to identify CCNE1 amplification...
3.
Bradbury P, Morris D, Nicholas G, Tu D, Tehfe M, Goffin J, et al.
Lung Cancer
. 2018 May;
120:142-148.
PMID: 29748010
Objectives: Pelareorep (reolysin), a Dearing strain of reovirus serotype 3, has demonstrated oncolytic activity as single agent and synergy with chemotherapy. We evaluated pelareorep, combined with standard second-line chemotherapy in...
4.
Chanda A, Chan A, Deng L, Kornaga E, Enwere E, Morris D, et al.
PLoS One
. 2017 May;
12(5):e0177639.
PMID: 28493978
Metastasis is the ultimate cause of breast cancer related mortality. Epithelial-mesenchymal transition (EMT) is thought to play a crucial role in the metastatic potential of breast cancer. Growing evidence has...
5.
Lawson K, Mostafa A, Shi Z, Spurrell J, Chen W, Kawakami J, et al.
Clin Cancer Res
. 2016 May;
22(23):5839-5850.
PMID: 27220962
Purpose: In addition to their direct cytopathic effects, oncolytic viruses are capable of priming antitumor immune responses. However, strategies to enhance the immunotherapeutic potential of these agents are lacking. Here,...
6.
Martin D, Hoff J, Gard R, Gregosky R, Jones H, Kirkwood C, et al.
Health Phys
. 2008 Jun;
95(1):36-46.
PMID: 18545028
The collection, processing, validation, verification, formatting, filing, and storage of the required input data are some of the most important components in the National Institute for Occupational Safety and Health...
7.
Stewart D, Bahlis N, Valentine K, Balogh A, Savoie L, Morris D, et al.
Blood
. 2006 Feb;
107(12):4623-7.
PMID: 16467197
A single center, prospective clinical trial was conducted evaluating 2 cycles of induction high-dose chemotherapy for adults younger than 65 years of age with aggressive non-Hodgkin lymphoma (NHL) and 2...
8.
Carlson L, Bultz B, Morris D
Health Qual Life Outcomes
. 2005 Jan;
3:7.
PMID: 15676074
Background: The purpose of this study was to evaluate the individualized and standardized quality of life (QL) and psychological distress of patients participating in a Phase I trial of the...
9.
Alain T, Thirukkumaran C, Morris D, Urbanski S, Janowska-Wieczorek A, Lee P, et al.
Clin Lymphoma
. 2003 Oct;
4(2):104-11.
PMID: 14556682
There are several well-documented cases in medical literature of the remission of leukemias and malignant lymphomas following natural human viral infections. In the hope of being able to reproduce these...
10.
Thirukkumaran C, Luider J, Stewart D, Cheng T, Lupichuk S, Nodwell M, et al.
Blood
. 2003 Mar;
102(1):377-87.
PMID: 12637331
Hematologic stem cell rescue after high-dose cytotoxic therapy is extensively used for the treatment of many hematopoietic and solid cancers. Gene marking studies suggest that occult tumor cells within the...